# MTRI (Inmed Pharmaceuticals Inc.) - SEC EDGAR Financial Statements

> Inmed Pharmaceuticals Inc. reported $1.31M in total assets and a net loss of $13.16M through June 30, 2026 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MTRI
- Markdown: https://convexityos.com/fundamentals/MTRI.md
- SEC CIK: 0001728328
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:07 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001728328&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | -- | Jun 30, 2026 |
| Operating Income | FY 2026 | -- | Operating profit |
| Net Income | FY 2026 | -$13.16M | GAAP bottom line |
| Diluted EPS | FY 2026 | -$2.41 | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $40K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $4.94M | $4.60M | $4.14M | $1.09M | $1.90M | -- |
| Cost of Revenue | -- | $3.24M | $3.50M | $2.73M | $546K | -- | -- |
| **Gross Profit** | -- | $1.71M | $1.10M | $1.40M | $544K | -- | -- |
| Research & Development | $3.03M | $2.82M | $3.22M | $3.73M | $7.28M | $5.34M | $5.81M |
| Total Operating Expenses | $11.61M | $8.47M | $9.30M | $9.83M | $17.81M | $9.94M | $9.15M |
| **Operating Income** | -- | -$6.77M | -$8.20M | -$7.95M | -$18.60M | -$10.20M | -- |
| **EBITDA** | -- | -$6.56M | -$7.98M | -$7.75M | -$18.41M | -$10.08M | -- |
| Interest Income | $245K | $156K | $528K | $492K | $96K | $16K | $130K |
| Income Before Tax | -$11.37M | -$8.69M | -$7.67M | -$7.93M | -$18.60M | -- | -- |
| Income Tax Expense | -- | -- | $7.1K | $13K | -- | -- | -- |
| **Net Income** | -$12.56M | -$1.70M | -$7.68M | -$7.95M | -$18.60M | -$10.20M | -$8.94M |
| Basic EPS | -$3.12 | -$8.36 | -$20.14 | -$65.00 | -$663.40 | -$759.20 | -$34.20 |
| **Diluted EPS** | -$3.12 | -$8.36 | -$20.14 | -$65.00 | -$663.40 | -$759.20 | -$34.20 |
| Basic Shares Outstanding | 4.2M | 975.9K | 381.1K | 122.4K | 28.0K | 13.4K | 261.0K |
| Diluted Shares Outstanding | 4.2M | 975.9K | 381.1K | 122.4K | 28.0K | 13.4K | 261.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $820K | $1.12M | $1.30M | $1.26M | $1.11M |
| Cost of Revenue | -- | -- | -- | $636K | $717K | $728K | $1.09M | $651K |
| **Gross Profit** | -- | -- | -- | $184K | $403K | $577K | $176K | $461K |
| Research & Development | $206K | $806K | $1.02M | $631K | $575K | $577K | $425K | $895K |
| Total Operating Expenses | $2.01M | $4.86M | $2.84M | $2.29M | $1.92M | $1.87M | $2.08M | $2.71M |
| **Operating Income** | -- | -- | -- | -$2.10M | -$1.52M | -$1.29M | -$1.91M | -$2.25M |
| **EBITDA** | -- | -- | -- | -$2.05M | -$1.47M | -$1.24M | -$1.86M | -$2.20M |
| Interest Income | $14K | $29K | $48K | $74K | $94K | $52K | $17K | $31K |
| Income Before Tax | -$2.00M | -$4.84M | -$2.79M | -$2.03M | -$1.83M | -$1.83M | -$2.07M | -$2.58M |
| **Net Income** | -$2.33M | -$5.84M | -$2.97M | -$2.03M | -$1.73M | $4.67M | -$2.12M | -$2.58M |
| Basic EPS | -$0.42 | -- | -$0.73 | -$0.51 | -$0.44 | -- | -$1.94 | -$3.64 |
| **Diluted EPS** | -$0.42 | -- | -$0.73 | -$0.51 | -$0.44 | -- | -$1.94 | -$3.64 |
| Basic Shares Outstanding | 5.5M | -- | 4.0M | 4.0M | 4.0M | -- | 1.1M | 706.5K |
| Diluted Shares Outstanding | 5.5M | -- | 4.0M | 4.0M | 4.0M | -- | 1.1M | 706.5K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $10.74M | $6.57M | $8.91M | $6.18M | $7.36M | $5.81M |
| Short-Term Investments | $40K | $43K | $43K | $44K | $45K | $46K | $42K |
| **Cash & Short-Term Investments** | $2.20M | $11.10M | $6.60M | $8.96M | $6.22M | $7.41M | $5.85M |
| Accounts Receivable, Net | -- | $465K | $353K | $260K | $88K | $12K | $45K |
| Inventory | -- | $961K | $1.24M | $1.62M | $2.49M | -- | -- |
| **Total Current Assets** | $2.68M | $12.87M | $8.69M | $11.33M | $9.60M | $8.38M | $6.31M |
| Property, Plant & Equipment, Net | $221K | $992K | $1.25M | $723K | $904K | $327K | $403K |
| Intangible Assets | -- | $1.62M | $1.78M | $1.95M | $2.11M | $1.06M | $1.09M |
| Other Non-Current Assets | $132K | $100K | $100K | $105K | $177K | $15K | -- |
| **Total Non-Current Assets** | $353K | $2.71M | $3.13M | $2.77M | $3.19M | $1.40M | $1.49M |
| **Total Assets** | $3.03M | $15.58M | $11.82M | $14.11M | $12.79M | $9.78M | $7.80M |
| Accounts Payable | $927K | $278K | $41K | $544K | $1.17M | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | $3.18M | $2.22M | -- |
| **Total Current Liabilities** | $1.96M | $1.84M | $1.97M | $2.00M | $3.32M | $2.22M | $1.68M |
| **Total Non-Current Liabilities** | $0 | $306K | $645K | $16K | $389K | $189K | $248K |
| **Total Liabilities** | $1.96M | $2.15M | $2.62M | $2.02M | $3.71M | $2.40M | $1.92M |
| **Total Debt (incl. Leases)** | -- | $741K | $963K | $392K | $825K | $385K | $317K |
| Common Stock | $94.28M | $91.22M | $82.78M | $77.62M | $70.72M | $60.59M | $53.07M |
| Retained Earnings | -$130.2M | -$117.2M | -$109.1M | -$101.4M | -$93.45M | -$74.85M | -$64.65M |
| Accumulated Other Comp. Income | $129K | $129K | $129K | $129K | $129K | $129K | -$302K |
| **Total Stockholders' Equity** | $1.08M | $13.43M | $9.21M | $12.09M | $9.08M | $7.38M | $5.88M |
| Total Equity | $1.08M | $13.43M | $9.21M | $12.09M | $9.08M | $7.38M | $5.88M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | $5.16M | $6.95M | $9.33M | $10.74M | $4.68M | $3.42M |
| Short-Term Investments | $40K | $40K | $42K | $43K | $43K | $43K | $41K | $41K |
| **Cash & Short-Term Investments** | $1.10M | $2.20M | $5.20M | $7.00M | $9.40M | $11.10M | $4.70M | $3.50M |
| Accounts Receivable, Net | -- | -- | -- | $183K | $343K | $465K | $368K | $263K |
| Inventory | -- | -- | -- | $948K | $891K | $961K | $814K | $1.10M |
| **Total Current Assets** | $1.26M | $2.68M | $6.89M | $8.79M | $10.80M | $12.87M | $6.41M | $5.47M |
| Property, Plant & Equipment, Net | -- | $221K | $643K | $764K | $882K | $992K | $1.11M | $1.23M |
| Intangible Assets | -- | -- | $1.50M | $1.54M | $1.58M | $1.62M | $1.66M | $1.70M |
| Other Non-Current Assets | $42K | $132K | $104K | $100K | $100K | $100K | $100K | $100K |
| **Total Non-Current Assets** | $42K | $353K | $2.25M | $2.40M | $2.56M | $2.71M | $2.87M | $3.03M |
| **Total Assets** | $1.31M | $3.03M | $9.13M | $11.19M | $13.36M | $15.58M | $9.28M | $8.50M |
| Accounts Payable | $1.67M | $927K | $225K | $167K | $369K | $278K | $560K | $575K |
| **Total Current Liabilities** | -- | $1.96M | $2.21M | $1.48M | $1.55M | $1.84M | $1.84M | $1.79M |
| **Total Non-Current Liabilities** | -- | $0 | $31K | $124K | $215K | $306K | $419K | $529K |
| **Total Liabilities** | $2.51M | $1.96M | $2.24M | $1.60M | $1.77M | $2.15M | $2.26M | $2.32M |
| **Total Debt (incl. Leases)** | -- | -- | $420K | $532K | $640K | $741K | $849K | $949K |
| Common Stock | $94.41M | $94.28M | $92.58M | $92.05M | $91.81M | $91.22M | $87.46M | $84.54M |
| Retained Earnings | -$132.6M | -$130.2M | -$124.0M | -$121.0M | -$119.0M | -$117.2M | -$115.4M | -$113.3M |
| Accumulated Other Comp. Income | $129K | $129K | $129K | $129K | $129K | $129K | $129K | $129K |
| **Total Stockholders' Equity** | -$1.20M | $1.08M | $6.89M | $9.59M | $11.59M | $13.43M | $7.02M | $6.18M |
| Total Equity | -$1.20M | $1.08M | $6.89M | $9.59M | $11.59M | $13.43M | $7.02M | $6.18M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.56M | -$1.70M | -$7.68M | $7.90M | $18.60M | $10.20M | $8.90M |
| Depreciation & Amortization | $205K | $213K | $220K | $202K | $186K | $121K | $112K |
| Stock-Based Compensation | $107K | $119K | $138K | $278K | $698K | $610K | $994K |
| Change in Receivables | -- | -$115K | -$92K | -$219K | -$40K | $40K | $17K |
| Change in Inventory | -- | $283K | $66K | $566K | -$2.00M | -- | -- |
| **Operating Cash Flow** | -$8.64M | -$8.10M | -$6.99M | -$7.28M | -$15.58M | -$9.79M | -$7.37M |
| Capital Expenditure | -- | -- | -$9.3K | -$160K | -$39K | -$1.7K | -$43K |
| **Free Cash Flow** | -- | -- | -$7.00M | -$7.44M | -$15.62M | -$9.79M | -$7.42M |
| Acquisitions, Net | -- | -- | -- | -$500K | -- | -- | -- |
| **Investing Cash Flow** | -- | -- | -$9.3K | -$662K | -$673K | -$1.7K | $3.79M |
| Common Stock Issued | -- | -- | -- | $12.00M | $17.15M | $12.47M | -- |
| **Financing Cash Flow** | $94K | $12.27M | $4.65M | $10.68M | $15.07M | $10.85M | -$31K |
| **Net Change in Cash** | -$8.55M | $4.17M | -$2.34M | $2.74M | -$1.19M | $1.56M | -$4.03M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.33M | -$5.84M | -$2.97M | -$2.03M | -$1.73M | $4.67M | -$2.12M | -$2.58M |
| Depreciation & Amortization | $168 | $48K | $51K | $53K | $53K | $53K | $52K | $53K |
| Stock-Based Compensation | $16K | $23K | $39K | $25K | $20K | $27K | $40K | $23K |
| Change in Receivables | -- | -- | -- | $160K | $122K | -$100K | -$105K | $23K |
| Change in Inventory | -- | -- | -- | -$127K | $70K | -$147K | $289K | $117K |
| **Operating Cash Flow** | -$1.14M | -$2.96M | -$1.70M | -$2.05M | -$1.93M | -$2.11M | -$1.66M | -$2.50M |
| **Investing Cash Flow** | $2.4K | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $40K | -$1 | $232K | $0 | -$137K | $8.17M | $2.92M | $339K |
| **Net Change in Cash** | -$1.10M | -$2.96M | -$1.46M | -$2.05M | -$2.07M | $6.06M | $1.26M | -$2.16M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 34.5% | 23.9% | 33.9% | 49.9% | -- | -- |
| **Operating Margin** | -- | -136.9% | -178.3% | -192.2% | -1707.3% | -535.9% | -- |
| **Net Profit Margin** | -- | -34.4% | -166.9% | -192.2% | -1707.3% | -535.9% | -- |
| Return on Equity (ROE) | -1168.4% | -12.7% | -83.4% | -65.7% | -204.9% | -138.3% | -152.1% |
| Return on Assets (ROA) | -414.5% | -10.9% | -64.9% | -56.3% | -145.5% | -104.3% | -114.6% |
| Current Ratio | 1.37x | 6.99x | 4.41x | 5.66x | 2.89x | 3.78x | 3.77x |
| Quick Ratio | 1.13x | 6.47x | 3.78x | 4.86x | 2.14x | 3.35x | 3.52x |
| Debt to Equity | -- | 0.06x | 0.10x | 0.03x | 0.09x | 0.05x | 0.05x |
| **Revenue Growth (YoY)** | -- | +7.5% | +11.2% | +279.6% | -42.8% | -- | -- |
| Gross Profit Growth (YoY) | -- | +55.0% | -21.5% | +158.1% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | 29.7% | 33.7% | 34.5% | 32.4% | 35.4% |
| **Operating Margin** | -- | -- | -- | -151.4% | -145.3% | -145.4% | -161.2% | -162.8% |
| **Net Profit Margin** | -- | -- | -- | -26.7% | -36.5% | -34.4% | -168.9% | -163.8% |
| Return on Equity (ROE) | -- | -1168.4% | -29.7% | -12.5% | -15.1% | -12.7% | -118.4% | -128.0% |
| Return on Assets (ROA) | -1008.1% | -414.5% | -22.4% | -10.7% | -13.1% | -10.9% | -89.6% | -93.1% |
| Current Ratio | -- | 1.37x | 3.11x | 5.94x | 6.95x | 6.99x | 3.49x | 3.05x |
| Quick Ratio | -- | 1.13x | 2.35x | 5.30x | 6.37x | 6.47x | 3.04x | 2.44x |
| Debt to Equity | -- | -- | 0.06x | 0.06x | 0.06x | 0.06x | 0.12x | 0.15x |
| **Revenue Growth (YoY)** | -- | -- | -- | -26.2% | -11.4% | +1.7% | +7.6% | -10.4% |
| Gross Profit Growth (YoY) | -- | -- | -- | -60.0% | -18.3% | +23.7% | -39.3% | +42.2% |
| **Net Income Growth (YoY)** | -- | -224.9% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
